Edition:
India

Aldeyra Therapeutics Inc (ALDX.OQ)

ALDX.OQ on NASDAQ Stock Exchange Capital Market

5.27USD
19 Jul 2019
Change (% chg)

-- (--)
Prev Close
$5.27
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
123,965
52-wk High
$16.70
52-wk Low
$4.99

Select another date:

Tue, Mar 26 2019

Aldeyra's eye drug meets main goal in late-stage study, shares surge

Aldeyra Therapeutics Inc said on Tuesday its drug reproxalap to treat a form of allergic reaction to the eye met the main goal in a late-stage trial, sending shares up more than 60 percent.

Aldeyra's eye drug meets main goal in late-stage study, shares surge

Aldeyra Therapeutics Inc said on Tuesday its drug reproxalap to treat a form of allergic reaction to the eye met the main goal in a late-stage trial, sending shares up more than 60 percent.

Aldeyra's eye drug meets main goal in late-stage study, shares surge

March 26 Aldeyra Therapeutics Inc said on Tuesday its drug reproxalap to treat a form of allergic reaction to the eye met the main goal in a late-stage trial, sending shares up more than 60 percent.

Select another date: